| CGACX | RSLDX | CGACX / RSLDX | |
| Total Expense Ratio | 1.99 | 0.80 | 249% |
| Annual Report Gross Expense Ratio | 2.24 | 0.80 | 280% |
| Fund Existence | 18 years | 10 years | - |
| Gain YTD | 29.816 | 13.225 | 225% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 161M | 82.3B | 0% |
| Annual Yield % from dividends | 0.05 | 0.76 | 6% |
| Returns for 1 year | 22.85 | 6.84 | 334% |
| Returns for 3 years | 17.04 | 31.03 | 55% |
| Returns for 5 years | 19.07 | 3.56 | 535% |
| Returns for 10 years | 119.47 | 65.95 | 181% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GHYG | 45.96 | 0.13 | +0.28% |
| iShares US & Intl High Yield Corp Bd ETF | |||
| QMMY | 24.85 | 0.06 | +0.22% |
| FT Vest Nasdaq-100 Mod Buffr ETF - May | |||
| RSPE | 29.33 | N/A | +0.01% |
| Invesco ESG S&P 500 Equal Weight ETF | |||
| VOE | 175.69 | -0.59 | -0.33% |
| Vanguard Mid-Cap Value ETF | |||
| LABU | 147.82 | -5.53 | -3.61% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||